• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Dipeptidyl Peptidase IV Inhibitors for Management of Type 2 Diabetes

Dipeptidyl Peptidase IV Inhibitors for Management of Type 2 Diabetes

Paperback

Chemistry

Currently unavailable to order

ISBN10: 6205508532
ISBN13: 9786205508534
Publisher: Lap Lambert Academic Pub
Published: Oct 3 2022
Pages: 84
Weight: 0.30
Height: 0.20 Width: 6.00 Depth: 9.00
Language: English
This book provides detailed summary about Dipeptidyl Peptidase IV (DPP IV) Inhibitors in Management of Type 2 Diabetes. DPP IV inhibitors are established therapy for managing blood glucose in patients with type 2 diabetes. Several DPP IV inhibitors are developed in last few years and are used clinically all over the world. This book describes role of Glucagon Like Peptide-1 (GLP-1), an incretin hormone in insulin secretion and how DPP IV inhibitors affect action of GLP-1. It is followed by chemistry of DPP IV inhibitors and their lead optimization strategies for clinical development.

Also in

Chemistry